Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block

Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block

Immune-related cardiotoxicities are uncommon but potentially fatal. The study aims to evaluate the value of pacemakers and methylprednisolone pulse therapy (MPPT) to patients with immune-related myocarditis concomitant with complete heart block (CHB). We first reviewed medical records of three patie...

Full description

Bibliographic Details
Main Authors: Hu Chunhong, Zhao Lishu, Zhou Chengzhi, Wang Hanping, Jiang Shun, Li Yizheng, Peng Yurong, Deng Chao, Ma Fang, Pan Yue, Shu Long, Huang Yan, Zeng Yue, Wu Fang
Format: Article
Language:English
Published: De Gruyter 2022-12-01
Series:Open Medicine
Subjects:
immune checkpoint inhibitor
myocarditis
complete heart block
pacemaker
methylprednisolone pulse therapy
Online Access:https://doi.org/10.1515/med-2022-0611

Internet

https://doi.org/10.1515/med-2022-0611

Similar Items